1. The use of nucleic acid amplification techniques to increase the viral safety of blood;Thomas;Clin Lab,2002
2. Current trends risks associated with human parvovirus infection. MMWR February 17, 1989;38:81–97.
3. Parvovirus B19—The need to screen. AmpliComm—Blood Screening Communications. vol. 1, Roche Molecular Systems, Inc. Summer 2002; p. 4–5.
4. Blood products and parvovirus B19;Groeneveld;Neth J Med,2003
5. Clinical manifestations and diagnosis of hepatitis A virus infection;Koff;Vaccine,1992